Dennis C. Liotta, Ph.D.

 

Dr. Dennis C. Liotta is the Samuel Candler Dobbs Professor of Chemistry at Emory University. Prof. Liotta received his Ph.D. in Organic Chemistry in 1974 from The City University of New York under Dr. Robert Engel and completed his post-doctoral training at The Ohio State University under Dr. Leo A. Paquette. Dr. Liotta has been a professor at Emory University for thirty-four years. He is a Fellow of the Alfred P. Sloan Foundation, the recipient of a Camille and Henry Dreyfus Teacher Scholar Fellowship, an Alexander von Humboldt Senior Scientist Award, the 2005 Herty Award, and was the Emory University Distinguished Faculty Lecturer for 2006. Along with his colleague, Raymond Schinazi, he was the recipient of the 2003 Biomedical Industry Growth Award, given by the Georgia Biomedical Partnership. He is currently the Director of the Emory Institute for Drug Discovery, as well as the co-director of the Republic of South Africa Drug Discovery Training Program.

While at Emory, Dr. Liotta has authored over two hundred research publications and approximately seventy issued US patents. Over the last twenty five years he has also developed a great deal of experience in the discovery and development of pharmaceuticals. He has served as a consultant to several major pharmaceutical firms, including Merck, Glaxo, Burroughs Wellcome, Boehringer Ingelheim and Johnson & Johnson. He serves (or has served) on the Scientific Advisory Boards (SABs) of several small biopharmaceutical companies including Altiris (scientific founder), Pharmasset (scientific founder), iThemba Pharmaceuticals (scientific founder, SAB Chair), NeurOp, and FOB Synthesis. In addition, he is the inventor of record for several clinically important agents, including FTC (Emtriva®, Emtricitabine), 3TC (Epivir®, Lamivudine), Reverset® (DPC 817, D-D4FC), Racivir, Elvucitabine and MSX-122.